| | | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $12,024,484 ) (Continued on the next page) |
| 2024 | 2024 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | UG1CA233323 | NCI National Clinical Trials Network - Network Lead Academic Participating Sites (UG1) | 001 | 6 | NIH | 4/17/2024 | $16,103 |
| 2024 | 2024 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | U1Q53034 | Geriatrics Workforce Enhancement Program | 00 | 1 | HRSA | 5/23/2024 | $719,494 |
| 2024 | 2024 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | R01HL174700 | Mechanisms of Impaired Inflammation Resolution in Cystic Fibrosis Lung Disease | 000 | 1 | NIH | 7/22/2024 | $635,396 |
| 2024 | 2024 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | R01CA292467 | Melanocyte PDL1 control of UVB-induced IFN-I | 000 | 1 | NIH | 7/8/2024 | $635,946 |
| 2024 | 2024 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | R01DA057729 | Harm Reduction for Smokers with Mental Illness: RCT of E-cigarette Provision with or without Behavioral Support to Boost Switching | 000 | 1 | NIH | 5/10/2024 | $740,533 |
| 2024 | 2024 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | R01DK137994 | Decision Making in Metoidioplasty and Phalloplasty Gender Affirming Surgery (MaPGAS) | 000 | 1 | NIH | 3/8/2024 | $341,426 |
| 2024 | 2024 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | R03HL173741 | Down syndrome and Psoriasis: An Investigation of Cardiometabolic Risk | 000 | 1 | NIH | 4/18/2024 | $155,000 |
| 2024 | 2024 | DARTMOUTH-HITCHCOCK CLINIC | ONE MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | K23DK134814 | A Fully Remote Pilot Randomized Controlled Trial to Investigate the Impact of Insomnia Treatment on Crohn’s disease | 000 | 2 | NIH | 11/28/2023 | $188,797 |
| 2024 | 2024 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | R01MH134141 | Evaluating the potential of neural oscillation biomarkers in a rodent model of intervention outcome variation: Toward personalized mental health care | 000 | 2 | NIH | 5/24/2024 | $579,872 |
| 2024 | 2024 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | NU58DP007541 | Increasing Epilepsy Self-Management Access by Embracing a HUB and Spoke Model | 00 | 2 | CDC | 6/21/2024 | $449,937 |
| 2024 | 2024 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | P20GM148278 | Center for Rural Health Care Delivery Science | 002 | 2 | NIH | 6/6/2024 | $230,892 |
| 2024 | 2024 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | P20GM148278 | Center for Rural Health Care Delivery Science | 001 | 2 | NIH | 4/26/2024 | $0 |
| 2024 | 2024 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | P20GM148278 | Center for Rural Health Care Delivery Science | 000 | 2 | NIH | 2/27/2024 | $2,078,042 |
| 2024 | 2024 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | K08HL165087 | Comparative-Effectiveness of Procedures for Carotid Revascularization | 000 | 2 | NIH | 5/15/2024 | $146,706 |
| 2024 | 2024 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | R01EY033712 | Impact of tissue resident memory T cells on the neuro-immunepathophysiology of anterior eye disease | 000 | 3 | NIH | 3/4/2024 | $443,406 |
| 2024 | 2024 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | R01ES034133 | Investigating Toxic Elements and Nanoparticles in ALS Etiology: A Geospatial and Toxicological Evaluation of Massachusetts ALS Registry Patients | 000 | 3 | NIH | 7/22/2024 | $461,158 |
| 2024 | 2024 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | K08CA263546 | Geospatial drivers of cancer care disparities and their susceptibility to health policy changes | 000 | 3 | NIH | 6/25/2024 | $173,880 |
| 2024 | 2024 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | T3232520 | NRSA for Primary Medical Care | 00 | 7 | HRSA | 7/2/2024 | $443,945 |
| 2024 | 2024 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | K08CA259632 | Increasing physical activity among breast cancer survivors: Use of the ORBIT Model to refine and test a novel approach to exercise promotion based on affect-regulation | 000 | 4 | NIH | 2/28/2024 | $174,492 |
| 2024 | 2024 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | U01AI163063 | Nuclear Receptor Networks in Mucosal Immune Regulation | 005 | 5 | NIH | 4/24/2024 | $395,214 |
| 2024 | 2024 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | K24HL150453 | Macrophage Pathogen Interactions in Regional Cystic Fibrosis Lung Inflammation | 000 | 5 | NIH | 4/24/2024 | $105,478 |
| 2024 | 2024 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | R01MD014735 | Urban-Rural Disparities in Healthcare Quality for Children with Complex or Disabling Health Conditions | 002 | 5 | NIH | 5/24/2024 | $30,000 |
| 2024 | 2024 | DARTMOUTH-HITCHCOCK CLINIC | ONE MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | R01MD014735 | Urban-Rural Disparities in Healthcare Quality for Children with Complex or Disabling Health Conditions | 001 | 5 | NIH | 11/17/2023 | $270,000 |
| 2024 | 2024 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | R01CA243449 | Optimizing colorectal cancer prevention: a multi-disciplinary, population-based investigation of serrated polyps using risk prediction and modeling | 000 | 5 | NIH | 6/3/2024 | $541,681 |
| 2024 | 2024 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | R01AR077157 | Real-time fluorescence-based measurement of bone perfusion in post-traumatic infection | 001 | 5 | NIH | 6/12/2024 | $27,611 |
| 2024 | 2024 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | R01AR077157 | Real-time fluorescence-based measurement of bone perfusion in post-traumatic infection | 000 | 5 | NIH | 4/17/2024 | $355,004 |
| 2024 | 2024 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | U1Q53034 | Geriatrics Workforce Enhancement Program | 00 | 1 | HRSA | 5/23/2024 | $280,221 |
| 2024 | 2024 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | UG1CA233323 | NCI National Clinical Trials Network - Network Lead Academic Participating Sites (UG1) | 000 | 6 | NIH | 3/6/2024 | $1 |
| 2024 | 2023 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | R21AI154039 | Transcript-selective translational control of Th17 cell development and function | 002 | 4 | NIH | 12/11/2023 | $123,438 |
| 2024 | 2023 | DARTMOUTH-HITCHCOCK CLINIC | ONE MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | R21AI154039 | Transcript-selective translational control of Th17 cell development and function | 003 | 4 | NIH | 1/11/2024 | $0 |
| 2024 | 2023 | DARTMOUTH-HITCHCOCK CLINIC | ONE MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | U1Q32519 | Geriatrics Workforce Enhancement Program | 03 | 6 | HRSA | 11/29/2023 | $0 |
| 2024 | 2023 | DARTMOUTH-HITCHCOCK CLINIC | ONE MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | T3232520 | NRSA for Primary Medical Care | 02 | 6 | HRSA | 1/30/2024 | $0 |
| 2024 | 2023 | DARTMOUTH-HITCHCOCK CLINIC | ONE MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | R01AI164772 | Nuclear Receptor Control of T Cell Function in Discrete Intestinal Microenvironments | 003 | 5 | NIH | 11/7/2023 | $0 |
| 2024 | 2023 | DARTMOUTH-HITCHCOCK CLINIC | ONE MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | U01AI163063 | Nuclear Receptor Networks in Mucosal Immune Regulation | 004 | 4 | NIH | 1/31/2024 | $0 |
| 2024 | 2023 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | U01AI163063 | Nuclear Receptor Networks in Mucosal Immune Regulation | 003 | 4 | NIH | 1/16/2024 | $42,544 |
| 2024 | 2023 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | U01AI163063 | Nuclear Receptor Networks in Mucosal Immune Regulation | 001 | 4 | NIH | 10/17/2023 | $191,705 |
| 2024 | 2023 | DARTMOUTH-HITCHCOCK CLINIC | ONE MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | R01MD014735 | Urban-Rural Disparities in Healthcare Quality for Children with Complex or Disabling Health Conditions | 000 | 4 | NIH | 10/7/2023 | $0 |
| 2024 | 2023 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | UG1OD024946 | ECHO IDeA States Pediatric Clinical Trials Network - 2 | 000 | 7 | NIH | 3/20/2024 | $0 |
| 2024 | 2023 | Dartmouth-Hitchcock Clinic | One Medical Center Dr | Lebanon | NH | 03756-1000 | GRAFTON | USA | NU58DP007541 | Increasing Epilepsy Self-Management Access by Embracing a HUB and Spoke Model | 01 | 1 | CDC | 12/6/2023 | $0 |
| 2024 | 2022 | DARTMOUTH-HITCHCOCK CLINIC | ONE MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | R21NS116434 | Longitudinal Measurement of Neurodegeneration in two Murine Models of Multiple Sclerosis: A Clinical and Histopathologic Validation Study | 000 | 2 | NIH | 2/9/2024 | $0 |
| 2024 | 2022 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | K01MH117496 | Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery | 000 | 4 | NIH | 3/13/2024 | $0 |
| 2024 | 2022 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | K08MH117347 | Computationally guided modulation of cortical-striatal activity: Toward brain stimulation-based treatments for impulsive and risky decision making | 000 | 4 | NIH | 6/24/2024 | $0 |
| 2024 | 2022 | DARTMOUTH-HITCHCOCK CLINIC | ONE MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | R01CA231325 | (PQ2) PD-L1/PD-1 signals in aged hosts undergoing cancer immunotherapy | 000 | 5 | NIH | 2/13/2024 | $0 |
| 2024 | 2022 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | K23MH116367 | Administrative Supplement for COVID-19 Impact on K23 Effectiveness and Implementation of Brief Cognitive-Behavioral Therapy for Health Anxiety in Primary Care | 000 | 5 | NIH | 10/12/2023 | $0 |
| 2024 | 2022 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | R01AI164772 | Nuclear Receptor Control of T Cell Function in Discrete Intestinal Microenvironments | 002 | 4 | NIH | 10/11/2023 | $1,187,539 |
| 2024 | 2021 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | R21DC018147 | Central auditory processing abnormalities as an indicator of pediatric heavy metal neurotoxicity | 000 | 2 | NIH | 3/18/2024 | -$8 |
| 2024 | 2021 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | R21DC018147 | Central auditory processing abnormalities as an indicator of pediatric heavy metal neurotoxicity | 000 | 2 | NIH | 3/18/2024 | -$302 |
| 2024 | 2021 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | R21DK124733 | Decision Making in Transmasculine Genital Reconstruction Surgery (TMGRS) | 000 | 2 | NIH | 12/27/2023 | -$7,448 |
| 2024 | 2021 | DARTMOUTH-HITCHCOCK CLINIC | 1 MEDICAL CENTER DR | LEBANON | NH | 03756-1000 | GRAFTON | USA | R00CA190890 | Molecular guided surgery for enhanced resection of solid tumors | 000 | 5 | NIH | 1/11/2024 | -$15,602 |
|